This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Larynx
CD2_BENIGN_LARYNX_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D14
- Name in latin
- Neoplasma benignum laryngis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Larynx
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Larynx
- Benign neoplasm of middle ear and respiratory system
- Benign neoplasm of middle ear and respiratory system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1179 | 386 | 793 |
| Unadjusted period prevalence (%) | 0.28 | 0.13 | 0.35 |
| Median age at first event (years) | 56.07 | 52.05 | 58.04 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1075
- Matched controls
- 10750
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
+∞
323.0
907
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
301.3
323.0
411
22
UDQ22
NOMESCO Finland
Microlaryngoscopy
315.6
269.0
263
11
UDQ12
NOMESCO Finland
Flexible laryngoscopy
20.2
199.3
313
214
DQA10
NOMESCO Finland
Biopsy of larynx
306.1
180.7
179
7
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
145.1
136
*
ZXC10
NOMESCO Finland
Use of laser
32.1
141.2
189
71
130
Kela drug reimbursment
Malignant tumour
+∞
128.8
121
*
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
450.0
123.4
121
*
21210
ICD-8 Finland
Benign neoplasm of respiratory system, Larynx
+∞
111.4
105
*
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
210.0
110.7
113
6
2121A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Larynx
+∞
104.9
99
*
1420
FHL
Laryngomicroscopy
79.4
101.7
114
16
J38.3
ICD-10 Finland
Other diseases of vocal cords
42.6
100.3
125
33
J37.0
ICD-10 Finland
Chronic laryngitis
17.2
95.8
156
105
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
89.8
85
*
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
55.8
89.6
106
21
C61
ICD-10 Finland
Malignant neoplasm of prostate
186.6
83.4
86
5
WF002
NOMESCO Finland
Radical radiotherapy
107.6
82.3
89
9
UDQ02
NOMESCO Finland
Direct laryngoscopy
79.5
78.5
88
12
8070/3-C32.0
ICD-O-3
Squamous cell carcinoma, NOS, of glottis
+∞
71.7
68
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.6
65.4
381
1438
8070/3-C32.9
ICD-O-3
Squamous cell carcinoma, NOS, of larynx, NOS
+∞
59.9
57
*
UJC01
NOMESCO Finland
Scopy of lower throat
37.0
59.4
76
22
116
Kela drug reimbursment
Prostate cancer
+∞
54.6
52
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
196.6
54.5
56
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.7
54.2
282
949
H02AB02
ATC
dexamethasone; systemic
22.6
53.5
78
37
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
118.0
52.3
56
5
A04AA02
ATC
granisetron; systemic, transdermal
267.4
50.5
51
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
27.2
50.0
69
27
A03FA01
ATC
metoclopramide; systemic, rectal
4.2
48.1
205
573
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.8
43.5
156
365
UDH02
NOMESCO Finland
Rhinopharyngoscopy
5.4
43.0
137
281
EP1AE
NOMESCO Finland
Neck ultrasound examination
7.5
43.0
106
155
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
+∞
43.0
41
*
ZXE00
NOMESCO Finland
One hour or less
2.5
41.3
479
2628
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
39.8
38
*
R49.0
ICD-10 Finland
Dysphonia
15.5
39.8
66
45
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
+∞
38.8
37
*
C32.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of larynx
+∞
37.7
36
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
37.2
459
2562
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
26.7
37.0
51
20
A02BC05
ATC
esomeprazole; systemic
2.4
36.9
480
2744
WX734
NOMESCO Finland
JET-ventilation
185.9
34.9
36
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
34.5
312
1463
XX3DW
NOMESCO Finland
Time consuming IT work
5.5
34.3
107
213
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.7
34.1
64
58
R49.08
ICD-10 Finland
Other specified dysphonia
11.3
34.0
65
61
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
28.2
33.9
46
17
B977, D141
ICD-10 Finland
NA
+∞
33.5
32
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
336.8
33.1
33
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
18.4
33.0
51
29
DQB30
NOMESCO Finland
Laryngectomy
+∞
32.4
31
*
WX402
NOMESCO Finland
General anaesthesia
3.2
32.2
192
686
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
90.4
31.9
35
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
31.4
30
*
L02AE02
ATC
leuprorelin; implant, parenteral
39.3
30.4
38
10
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
310.6
29.9
30
*
R49.01
ICD-10 Finland
Functional dysphonia
7.7
29.9
71
98
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
+∞
29.3
28
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
29.3
28
*
A02BC02
ATC
pantoprazole; systemic
2.1
29.2
697
5019
ZX090
NOMESCO Finland
Other technic of radiotherapy
299.5
28.9
29
*
N02AA05
ATC
oxycodone; systemic
3.1
28.4
170
608
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
28.2
27
*
R13
ICD-10 Finland
Dysphagia
4.2
27.9
112
290
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
27.2
26
*
DQB70
NOMESCO Finland
Total excision of vocal cord
+∞
26.1
25
*
H02AB06
ATC
prednisolone; systemic
2.0
26.0
516
3381
WF049
NOMESCO Finland
Radiotherapy of metastasis
266.6
25.8
26
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
18.3
25.4
39
22
JN4BD
NOMESCO Finland
Extensive body CT
4.5
25.2
94
226
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
25.1
24
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
24.6
392
2337
UJC02
NOMESCO Finland
Rigid oesophagoscopy
17.4
23.7
37
22
J38.7
ICD-10 Finland
Other diseases of larynx
27.4
23.6
32
12
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
23.2
463
2997
JDB10
NOMESCO Finland
Percutaneous gastrostomy
12.5
22.9
41
34
J38.2
ICD-10 Finland
Nodules of vocal cords
26.5
22.7
31
12
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.1
22.2
130
455
L02BB03
ATC
bicalutamide; oral
+∞
21.9
21
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
21.9
21
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
21.8
326
1872
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
27.0
21.4
29
11
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.4
21.0
78
187
GB3AV
NOMESCO Finland
NA
+∞
20.9
20
*
R07.0
ICD-10 Finland
Pain in throat
4.0
20.4
84
222
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.5
20.2
173
761
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.1
20.1
65
135
Z51.5
ICD-10 Finland
Palliative care
6.6
20.1
52
82
GBB00
NOMESCO Finland
Tracheostomy
9.8
19.5
39
41
UJF32
NOMESCO Finland
Coloscopy
2.1
18.8
270
1510
115
Kela drug reimbursment
Breast cancer
+∞
18.8
18
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
18.8
18
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
18.8
18
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
18.2
489
3414
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
17.7
17
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
50.8
17.0
20
*
JN4AD
NOMESCO Finland
Body CT examination
4.5
16.9
60
138
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
16.7
16
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
16.7
16
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
35.6
16.7
21
6
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.1
16.6
65
165
A07AA02
ATC
nystatin; oral
3.5
16.2
78
236
R03AC02
ATC
salbutamol; inhalant
1.7
16.1
508
3680
A04AA01
ATC
ondansetron; systemic, rectal
6.0
16.0
44
76
WZC30
NOMESCO Finland
Teaching
2.7
16.0
117
471
J01DA01
ATC
[U] cefalexin; systemic
1.7
16.0
645
5021
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
15.7
15
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
15.7
15
*
D10.7
ICD-10 Finland
Benign neoplasm: Hypopharynx
+∞
15.7
15
*
Y77
ICPC
Malignant neoplasm prostate
86.3
15.6
17
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
162.2
15.5
16
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
162.2
15.5
16
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
38.6
15.4
19
5
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
10.2
15.0
29
29
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
14.6
14
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
14.6
14
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
14.6
14
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
14.6
14
*
4509
FHL
Other measure in this category
151.9
14.5
15
*
4760A
ICD-9 Finland
Chronic laryngitis and laryngotracheitis, Chronic laryngitis
36.5
14.5
18
5
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
27.6
14.3
19
7
R03BB04
ATC
tiotropium bromide; inhalant
2.3
14.2
145
693
J01AA02
ATC
doxycycline; systemic
1.7
14.1
786
6587
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
14.0
333
2192
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.5
13.7
111
469
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
7.7
13.7
31
41
A04AD12
ATC
aprepitant; systemic
+∞
13.6
13
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
13.6
13
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
13.6
13
*
GBB13
NOMESCO Finland
Revision of tracheostomy
+∞
13.6
13
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
13.6
13
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
13.6
13
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
13.6
13
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
13.6
13
*
ZXB10
NOMESCO Finland
Medial
16.4
13.5
21
13
GD1AD
NOMESCO Finland
Thorax CT examination
3.9
13.4
55
147
J01MA12
ATC
levofloxacin; systemic
2.0
13.3
196
1092
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
13.2
372
2563
A02BC03
ATC
lansoprazole; oral
1.7
13.1
316
2079
R49.09
ICD-10 Finland
Unspecified dysphonia
8.0
13.1
29
37
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
12.9
218
1278
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.6
12.6
56
160
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
70.7
12.6
14
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
32.4
12.6
16
5
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
12.5
12
*
8070/3-C32.1
ICD-O-3
Squamous cell carcinoma, NOS, of supraglottis
+∞
12.5
12
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
12.5
12
*
L01BC06
ATC
capecitabine; oral
+∞
12.5
12
*
N07BA03
ATC
varenicline; oral
3.3
12.4
63
200
A02BC01
ATC
omeprazole; systemic
1.7
12.3
292
1906
UDC00
NOMESCO Finland
Ear microscopy
2.6
12.1
87
347
1430
FHL
Laryngoscopy (direct)
21.5
12.0
17
8
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.3
11.9
43
102
4784A
ICD-9 Finland
Other diseases of upper respiratory tract, Polyp of vocal cord or larynx[POLYPUS PLICAE VOCALIS]
30.4
11.7
15
5
J01DB01
ATC
cefalexin; oral
1.6
11.6
789
6749
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
11.6
204
1210
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
11.5
11
*
C14.1
ICD-10 Finland
Malignant neoplasm of laryngopharynx unspecified
+∞
11.5
11
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
11.5
11
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.4
11.4
29
46
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
5.7
11.4
32
58
N02BE01
ATC
paracetamol; systemic, rectal
1.7
11.3
836
7280
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.2
11.3
42
103
R06.0
ICD-10 Finland
Dyspnoea
1.7
11.3
252
1609
L03AA02
ATC
filgrastim; parenteral
25.3
11.2
15
6
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
25.3
11.2
15
6
N02AX02
ATC
tramadol; systemic, rectal
1.6
11.1
416
3062
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
11.0
212
1290
ZXD20
NOMESCO Finland
Day surgery
2.0
10.8
137
717
ENA10
NOMESCO Finland
Biopsy of pharynx
18.0
10.7
16
9
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
10.7
160
892
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.2
10.6
105
494
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.6
10.4
77
312
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
111.0
10.4
11
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
111.0
10.4
11
*
8070/2-C32.0
ICD-O-3
Squamous cell carcinoma in situ, NOS, of glottis
+∞
10.4
10
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
10.4
10
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
10.4
10
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
10.4
10
*
50808
ICD-8 Finland
Other diseases of upper respiratory tract, Alii definiti
16.2
10.4
16
10
WW500
NOMESCO Finland
Blood transfusion
5.2
10.3
31
61
Z50.5
ICD-10 Finland
Speech therapy
6.1
10.3
27
45
WX002
NOMESCO Finland
Sedation and analgesia
1.8
10.3
190
1141
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
23.6
10.2
14
6
ZXA05
NOMESCO Finland
Left side
1.7
10.2
260
1719
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
10.1
278
1878
UJC12
NOMESCO Finland
Flexible oesophagoscopy
14.7
10.0
16
11
HAB40
NOMESCO Finland
Wedge excision of mammary gland
14.7
10.0
16
11
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
40.4
10.0
12
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
40.4
10.0
12
*
J01FA10
ATC
azithromycin; systemic
1.5
9.8
495
3871
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
15.2
9.5
15
10
R04.2
ICD-10 Finland
Haemoptysis
3.2
9.4
49
160
J01CA04
ATC
amoxicillin; systemic
1.5
9.4
754
6501
D02.0
ICD-10 Finland
Carcinoma in situ: Larynx
+∞
9.4
9
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
9.4
9
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
9.4
9
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
9.4
9
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
9.4
9
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
9.4
9
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
9.4
9
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
9.4
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
21.9
9.4
13
6
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
8.8
9.3
19
22
ZXA10
NOMESCO Finland
Bilateral
1.8
9.2
180
1100
KCD02
NOMESCO Finland
Transurethral resection of bladder
11.6
9.1
16
14
J02AC01
ATC
fluconazole; systemic
1.6
9.1
303
2145
UGB02
NOMESCO Finland
Tracheoscopy
37.0
9.0
11
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.1
8.9
48
161
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
8.9
79
353
A02BA02
ATC
ranitidine; systemic
1.7
8.9
204
1303
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
8.7
8.8
18
21
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.4
8.8
72
307
E0000UV
ATC
NA
1.5
8.8
334
2433
ZXA00
NOMESCO Finland
Right side
1.6
8.8
261
1791
WX110
NOMESCO Finland
Local anesthesy
1.5
8.7
599
4954
H02AB07
ATC
prednisone; oral
1.8
8.7
145
840
R4130
NOMESCO Finland
Speech therapy
4.1
8.7
32
79
HAC20
NOMESCO Finland
Total mastectomy
50.4
8.7
10
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
50.4
8.7
10
*
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
8.6
124
680
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.8
8.6
54
199
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
8.6
102
519
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.9
8.6
34
90
H02AB04
ATC
methylprednisolone; systemic
1.8
8.5
148
869
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
8.4
169
1039
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
90.7
8.4
9
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
90.7
8.4
9
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
12.9
8.4
14
11
R95
ICPC
Chron obstructive pulmonary disease
3.3
8.4
41
129
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
8.3
8
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
8.3
8
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
8.3
8
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
8.3
8
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
8.3
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
8.3
8
*
C13.9
ICD-10 Finland
Malignant neoplasm: Hypopharynx, unspecified
+∞
8.3
8
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
8.3
8
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
8.3
8
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
8.3
8
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
8.3
8
*
J39.2
ICD-10 Finland
Other diseases of pharynx
7.1
8.3
19
27
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
6.1
8.2
21
35
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.3
8.0
73
331
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
4.6
7.9
26
58
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
7.9
46
163
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.7
7.9
52
200
ZX120
NOMESCO Finland
Intravenous
2.3
7.8
72
329
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
7.6
634
5376
NK6AN
NOMESCO Finland
Total body bone isotope imaging
18.5
7.6
11
6
N06AX16
ATC
venlafaxine; oral
1.9
7.6
107
586
R01AD09
ATC
mometasone; nasal
1.5
7.6
370
2827
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
7.5
156
965
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.3
7.5
68
309
J20
ICD-10 Finland
Acute bronchitis
2.1
7.5
88
445
R01AD08
ATC
fluticasone; nasal
1.6
7.5
240
1669
N05BA01
ATC
diazepam; systemic, rectal
1.8
7.5
136
808
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.7
7.5
49
188
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
80.6
7.4
8
*
C320, 8077, 2
ICD-O-3
NA
80.6
7.4
8
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
80.6
7.4
8
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.3
7.4
21
40
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
5.3
7.4
21
40
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.7
7.4
30
82
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
13.5
7.4
12
9
PJA10
NOMESCO Finland
Exploration of lymph nodes
13.5
7.4
12
9
J01FA06
ATC
roxithromycin; oral
1.5
7.4
370
2840
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
7.3
206
1389
DQW99
NOMESCO Finland
Other operation on larynx
+∞
7.3
7
*
C32.2
ICD-10 Finland
Malignant neoplasm: Subglottis
+∞
7.3
7
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
7.3
7
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
7.3
7
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
7.3
7
*
J38.6
ICD-10 Finland
Stenosis of larynx
+∞
7.3
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.3
7
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
7.3
7
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
7.3
7
*
C32
ICD-10 Finland
Malignant neoplasm of larynx
+∞
7.3
7
*
S18
ICPC
Laceration/cut
1.5
7.3
356
2715
UKC02
NOMESCO Finland
Cystoscopy
1.7
7.3
157
986
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.9
7.3
115
652
A01AB09
ATC
miconazole; local oral
2.0
7.3
86
438
P01AB01
ATC
metronidazole; oral, rectal
1.5
7.2
329
2474
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.1
7.2
80
398
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
15.9
7.2
11
7
D70.82
ICD-10 Finland
Drug-induced neutropenia
15.9
7.2
11
7
R23
ICPC
Voice symptom/complaint
4.1
7.2
26
64
R21
ICPC
Throat symptom/complaint
1.7
7.2
145
889
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
7.2
192
1273
E000001
ATC
NA
1.6
7.2
179
1168
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
3.1
7.2
37
122
H03AA01
ATC
levothyroxine sodium; systemic
1.6
7.1
178
1163
J01MA01
ATC
ofloxacin; systemic
2.0
7.0
93
496
R03BA05
ATC
fluticasone; inhalant
1.7
7.0
162
1033
WX400
NOMESCO Finland
Inhalation anesthesy
2.9
7.0
41
147
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.9
7.0
96
519
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
6.9
166
1071
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
6.9
856
7760
J31.0
ICD-10 Finland
Chronic rhinitis
2.2
6.9
69
329
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.5
6.9
30
87
N05CF01
ATC
zopiclone; oral
1.5
6.9
301
2242
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
6.8
89
470
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
6.8
42
156
JN4CD
NOMESCO Finland
Very extensive body CT
4.0
6.8
25
63
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.9
6.8
26
68
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
40.3
6.8
8
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
6.8
116
676
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
6.7
152
966
R53
ICD-10 Finland
Malaise and fatigue
1.6
6.7
186
1247
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
6.6
362
2810
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
6.5
319
2422
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
6.5
239
1716
R85
ICPC
Malignant neopl respiratory other
70.2
6.4
7
*
JN6AD
NOMESCO Finland
CT of torso and neck
14.4
6.4
10
7
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
2.8
6.4
39
145
M02AA07
ATC
piroxicam; topical
1.4
6.3
343
2655
N03AX16
ATC
pregabalin; oral
1.5
6.3
209
1460
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
6.3
71
358
C13.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of hypopharynx
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
6.3
6
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
6.3
6
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
6.3
6
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
6.3
6
*
L02BX03
ATC
abiraterone; oral
+∞
6.3
6
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
6.3
6
*
DQB00
NOMESCO Finland
Excision of lesion of larynx
+∞
6.3
6
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
6.3
6
*
D14.2
ICD-10 Finland
Benign neoplasm: Trachea
+∞
6.3
6
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
6.3
6
*
R50.9
ICD-10 Finland
Fever, unspecified
1.8
6.2
115
688
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
6.2
410
3293
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
6.1
155
1017
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.1
6.1
22
55
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.9
6.1
23
60
Z72.0
ICD-10 Finland
Tobacco use
3.4
6.1
27
81
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
6.1
270
2009
J01MA02
ATC
ciprofloxacin; systemic
1.4
6.0
359
2825
ZXC96
NOMESCO Finland
Robot assisted procedure
10.1
6.0
11
11
M54.5
ICD-10 Finland
Low back pain
1.5
6.0
272
2032
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
6.1
6.0
15
25
EBA10
NOMESCO Finland
Surgical removal of tooth
1.9
6.0
83
452
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
560
2563
3.26
85.56
2.9
1.7
—
—
—
0
0
(4035726)
142
243
6.51
81.16
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
172
647
2.94
33.44
1.4
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
601
4114
1.94
27.00
6.6
4.0
umol/l
12.6
12.3
0.10
570
3864
(3012095) Magnesium [Moles/volume] in Serum or Plasma
247
1246
2.24
25.53
4.5
2.8
mmol/l
0.8
0.8
3.69
237
1148
(3013650) Neutrophils [#/volume] in Blood by Automated count
644
4609
1.88
24.27
8.8
6.7
e9/l
4.3
4.3
0.17
572
3992
(3024561) Albumin [Mass/volume] in Serum or Plasma
521
3495
1.88
24.00
4.7
3.9
g/l
34.8
35.6
2.43
481
3215
(3002582) Erythrocytes [#/volume] in Urine
395
2486
1.89
21.70
3.6
3.0
e6/l
36.0
84.1
0.99
312
1901
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
111
417
2.83
21.35
3.4
1.5
ug/l
10.5
3.6
0.58
91
315
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
530
3668
1.81
21.32
4.5
3.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
821
6511
1.86
20.62
8.6
5.5
u/l
82.9
76.4
1.11
775
6030
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
453
3046
1.79
19.65
3.7
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
434
2909
1.78
18.84
3.9
3.4
e6/l
38.0
112.3
2.48
329
2052
(3000850) Epithelial cells [#/volume] in Urine
287
1717
1.89
17.92
2.9
2.4
e6/l
4.1
4.8
0.46
241
1503
(3006315) Basophils [#/volume] in Blood
569
4172
1.70
17.56
5.9
5.6
e9/l
0.0
0.0
0.40
496
3601
(3019198) Lymphocytes [#/volume] in Blood
577
4262
1.69
17.20
6.0
5.7
e9/l
2.1
1.9
0.85
513
3738
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
563
4137
1.69
17.07
6.7
5.7
mmol/l
1.2
1.2
0.45
467
3512
(3013115) Eosinophils [#/volume] in Blood
582
4315
1.69
17.06
6.1
5.9
e9/l
0.2
0.2
2.08
519
3783
(3013826) Glucose [Moles/volume] in Serum or Plasma
669
5176
1.68
16.42
5.0
4.6
mmol/l
6.6
6.8
1.70
650
4836
(3044640) Blood type and Crossmatch panel - Blood
359
2355
1.75
16.32
2.4
2.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
531
3874
1.67
16.30
6.3
5.8
%
2.7
3.0
2.16
500
3591
(3001604) Monocytes [#/volume] in Blood
561
4154
1.67
16.25
5.9
5.6
e9/l
0.6
0.6
0.61
488
3578
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
40
93
4.42
16.02
1.1
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
519
3778
1.67
15.97
5.7
5.3
mmol/l
1.2
1.2
0.42
483
3358
(3030467) Casts [#/volume] in Urine by Automated count
345
2251
1.75
15.92
3.4
2.9
e6/l
0.3
0.4
0.48
257
1685
(3002030) Lymphocytes/100 leukocytes in Blood
540
3977
1.66
15.84
6.3
5.9
%
26.8
27.5
0.67
504
3685
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
43
107
4.13
15.78
1.3
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
530
3888
1.66
15.77
6.5
6.1
%
8.9
8.8
0.32
501
3625
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
77
280
2.87
15.70
2.5
3.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
695
5472
1.66
15.57
5.4
4.1
e6/l
369.1
918.4
0.50
14
83
(3022096) Basophils/100 leukocytes in Blood
514
3751
1.66
15.54
6.2
5.9
%
0.6
0.7
2.15
481
3482
(42870588) Differential panel, method unspecified - Blood
401
2757
1.69
15.16
5.9
5.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
350
2333
1.71
14.77
4.4
4.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
222
1294
1.88
14.75
20.2
27.4
inr
1.3
1.4
0.26
52
183
(3007853) Bacteria identified in Skin by Aerobe culture
181
989
1.98
14.57
1.8
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
379
2596
1.68
14.38
3.2
2.0
mmol/l
2.4
2.3
0.09
334
2144
(3018010) Neutrophils/100 leukocytes in Blood
529
3945
1.62
14.29
6.2
5.8
%
58.4
57.6
0.81
497
3679
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
233
1403
1.82
13.89
2.1
1.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
307
2026
1.70
13.22
3.7
3.6
%
87.2
85.4
0.53
300
1968
(36304419) Bacteria [Presence] in Urine
324
2202
1.65
12.35
3.5
2.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
282
1849
1.69
12.33
2.4
2.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
16
20
8.10
11.90
1.1
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
230
1452
1.73
11.48
2.7
2.1
mmol/l
2.5
2.4
3.07
200
1232
(40768797) Stomach Pathology biopsy report
191
1154
1.78
11.09
1.3
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
369
2646
1.57
11.06
2.8
2.3
u/l
55.9
58.7
0.73
342
2429
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
151
850
1.89
11.01
4.6
3.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
474
3602
1.53
10.90
9.4
10.7
inr
1.3
1.4
1.53
137
998
(3018418) pH of Serum or Plasma
338
2388
1.58
10.75
4.2
3.2
ph
7.4
7.4
0.04
76
403
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
149
856
1.85
10.17
2.5
2.5
umol/l
11.7
8.6
0.31
130
746
(3013707) Erythrocyte sedimentation rate by Westergren method
764
6476
1.51
10.03
4.8
4.0
mm/h
13.6
11.7
2.59
715
5951
(3042936) Bacteria identified in Isolate by Culture
193
1205
1.72
9.93
1.8
2.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
306
2157
1.57
9.68
2.3
2.2
mg/l
3.0
2.9
0.37
273
1798
(3026782) Osmolality of Urine
238
1594
1.62
9.31
3.1
2.5
mosm/kgh2o
546.5
560.3
0.45
205
1332
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
152
2.90
9.30
1.6
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
31
91
3.47
9.09
1.8
3.0
%
2.0
1.1
0.48
21
70
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
200
1296
1.65
8.90
3.2
2.7
e6/l
1.8
1.6
0.16
109
700
(40758558) Short blood count panel - Blood
275
1924
1.56
8.90
7.0
4.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
211
1390
1.63
8.79
2.9
2.6
e6/l
0.9
1.0
0.31
119
790
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
17
32
5.38
8.70
3.0
2.0
nmol/l
12.6
3.1
0.50
17
32
(3037467) Urinalysis macro (dipstick) panel - Urine
698
5902
1.45
8.59
5.0
3.9
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
89
461
2.01
8.27
1.6
1.4
g/l
1.4
1.2
0.48
83
425
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
9
14.59
8.21
1.1
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
71
340
2.16
8.12
2.2
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
103
575
1.87
7.69
2.1
2.2
g/l
10.2
11.0
1.00
97
528
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
744
6434
1.42
7.64
4.2
3.5
pmol/l
15.0
14.8
0.75
666
5806
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
963
8762
1.54
7.49
20.1
13.0
mg/l
24.7
24.4
0.13
836
6805
(3004789) Transferrin [Mass/volume] in Serum or Plasma
182
1205
1.60
7.36
2.2
2.4
g/l
2.4
2.3
0.86
176
1113
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
593
4954
1.40
7.29
2.9
2.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
113
661
1.78
7.26
2.9
2.0
g/l
0.2
0.2
0.31
108
592
(3027945) Reticulocytes/100 erythrocytes in Blood
159
1022
1.64
7.25
2.1
2.1
%
1.8
1.8
0.60
148
899
(3003458) Phosphate [Moles/volume] in Serum or Plasma
169
1103
1.62
7.25
5.0
5.4
mmol/l
1.0
1.0
0.28
157
1007
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
469
3773
1.40
7.16
2.0
2.0
pmol/l
95.6
93.8
0.35
254
1992
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
169
1109
1.61
7.08
2.3
2.5
%
21.4
23.7
1.15
149
944
(3013512) EKG study
345
2634
1.44
7.06
4.7
3.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
113
669
1.76
6.97
4.0
3.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
249
1796
1.49
6.81
4.1
3.9
ng/l
315.7
487.2
0.90
191
1467
(3000494) Fungus identified in Specimen by Culture
154
998
1.62
6.79
1.5
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
192
1317
1.55
6.64
2.2
2.4
umol/l
11.9
13.4
1.87
182
1205
(3012501) Base excess in Blood by calculation
43
182
2.41
6.60
4.4
4.5
mmol/l
2.7
2.5
0.15
29
117
(3001122) Ferritin [Mass/volume] in Serum or Plasma
433
3477
1.39
6.53
3.0
2.7
ug/l
156.0
142.5
0.24
410
3185
(3010421) pH of Blood
49
222
2.26
6.46
4.0
4.3
ph
7.4
7.4
2.44
42
179
(3018677) aPTT in Platelet poor plasma by Coagulation assay
191
1319
1.53
6.40
1.8
1.9
s
29.6
30.0
0.47
185
1271
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
344
2666
1.41
6.37
3.7
2.8
u/l
30.1
34.7
1.85
326
2530
(3007164) IgA [Mass/volume] in Serum or Plasma
209
1474
1.51
6.34
1.4
1.3
g/l
2.8
2.7
0.19
141
890
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
62
314
2.03
6.18
2.3
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
103
615
1.74
6.18
5.7
3.6
kpa
5.3
5.2
0.81
96
567
(3026008) Bacteria identified in Urine by Culture
301
2292
1.42
6.12
3.6
3.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
121
758
1.66
6.09
5.0
6.5
mmol/l
1.5
1.5
0.05
114
733
(3044889) 12 lead EKG panel
721
6322
1.36
6.06
4.7
3.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
81
455
1.84
5.96
5.5
3.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
129
826
1.63
5.96
1.5
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
244
1798
1.45
5.91
1.7
1.7
mg/l
0.9
1.1
1.36
193
1374
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
152
1015
1.57
5.90
5.7
7.5
kpa
5.2
5.1
0.16
147
973
(3027801) Oxygen [Partial pressure] in Arterial blood
152
1015
1.57
5.90
5.7
7.4
kpa
12.1
11.5
0.55
146
973
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
35
142
2.51
5.90
3.8
3.6
%
60.2
58.1
0.42
35
142
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
877
7956
1.40
5.84
5.2
4.3
mu/l
2.1
2.1
0.10
800
7214
(3003396) Base excess in Arterial blood by calculation
151
1011
1.57
5.80
5.7
7.5
mmol/l
1.4
1.3
0.16
121
783
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
97
581
1.73
5.77
5.6
3.6
mmol/l
2.0
1.8
0.14
81
430
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
25
86
2.95
5.75
3.8
1.8
u/ml
45.8
65.1
0.21
20
78
(3009343) pH of Capillary blood
100
605
1.71
5.74
5.8
3.7
ph
7.4
7.4
0.66
11
76
(3030905) Polymorphonuclear cells [#/volume] in Blood
34
138
2.51
5.73
3.5
3.3
e9/l
4.4
4.3
0.05
34
138
(1616796) Gas panel - Central venous blood
41
182
2.30
5.70
4.2
3.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
59
304
1.99
5.63
3.1
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
243
1813
1.43
5.48
4.2
4.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
151
1034
1.53
5.24
5.4
6.4
mmol/l
104.3
104.4
0.09
146
1006
(3023520) Reticulocytes [#/volume] in Blood
117
756
1.61
5.22
2.7
2.2
e9/l
74.4
68.9
0.91
95
581
(40768800) Prostate Pathology biopsy report
22
75
2.97
5.16
1.1
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
991
9253
1.45
5.05
21.6
15.5
mmol/l
139.5
139.8
3.51
975
8990
(3021901) Oxygen saturation in Capillary blood
38
173
2.24
5.01
3.9
2.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
500
4234
1.31
4.94
3.8
3.4
estimate
0.0
0.0
0.80
103
697
(3023419) Bacteria identified in Sputum by Culture
32
136
2.39
4.93
2.3
2.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
39
181
2.19
4.92
1.1
1.2
—
556.0
—
0
5
(3026389) Candida sp identified in Specimen by Organism specific culture
24
89
2.73
4.86
1.9
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
111
721
1.60
4.86
5.8
7.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
145
1001
1.51
4.84
2.2
1.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
115
754
1.58
4.84
6.9
7.0
mmol/l
9.5
10.4
0.79
109
709
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
145
1003
1.51
4.80
2.2
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
493
4184
1.31
4.73
4.7
4.5
estimate
0.0
0.0
0.50
106
732
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1006
9446
1.44
4.71
12.0
9.0
u/l
27.5
27.4
0.03
978
9051
(3048689) Calprotectin [Mass/mass] in Stool
133
907
1.53
4.71
2.9
2.3
ug/g
166.9
148.3
0.14
102
720
(46235355) HIV 1 and 2 tests - Meaningful Use set
158
1118
1.48
4.68
1.7
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
899
8292
1.35
4.64
17.4
11.7
ml/min/173m2
80.2
78.7
1.17
781
6684
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
65
371
1.80
4.60
1.5
1.6
g/l
1.7
1.5
1.05
55
318
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
5
14.07
4.58
5.0
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
990
9281
1.42
4.57
21.8
15.6
mmol/l
4.0
4.0
0.32
974
9005
(3019309) Folate [Moles/volume] in Red Blood Cells
230
1752
1.39
4.55
1.7
1.8
nmol/l
1261.1
1139.1
1.05
182
1323
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
18
59
3.08
4.53
1.9
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
89
558
1.64
4.51
1.9
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
344
2795
1.33
4.47
3.3
3.0
ng/l
1172.4
1524.4
1.41
299
2358
(3035350) Ketones [Presence] in Urine by Test strip
490
4179
1.30
4.46
3.7
3.3
estimate
0.0
0.0
0.00
105
727
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
108
712
1.57
4.45
2.3
2.2
u/l
29.6
39.4
0.78
80
589
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
60
338
1.82
4.44
1.8
1.7
ug/l
3.1
1.8
0.45
54
297
(3029937) Albumin [Presence] in Urine by Test strip
286
2266
1.35
4.40
4.3
3.7
estimate
0.0
0.0
0.88
101
705
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38
183
2.11
4.40
1.9
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
91
578
1.62
4.38
3.3
3.9
%
0.5
0.5
0.01
26
112
(40768793) Breast Pathology biopsy report
15
45
3.36
4.33
1.1
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
84
525
1.65
4.31
2.0
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
402
3353
1.30
4.29
2.2
2.2
nmol/l
75.7
76.7
0.27
369
2943
(3019225) pH of Specimen
121
828
1.51
4.22
4.5
3.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
36
3.64
4.21
1.2
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
429
3619
1.29
4.18
4.8
3.8
ng/l
43.4
71.7
0.82
317
2568
(3017181) Myelocytes/100 leukocytes in Blood
96
629
1.57
4.08
3.3
4.0
%
0.6
0.8
0.55
35
143
(3042631) Mycobacterium sp identified in Specimen
25
105
2.41
4.00
2.8
2.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
60
351
1.75
3.95
2.0
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
636
5661
1.27
3.93
3.8
3.0
u/l
65.0
50.3
1.35
591
5234
(3052851) Hemolysis interference index of Serum or Plasma
45
241
1.90
3.92
3.8
3.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
45
241
1.90
3.92
4.8
3.2
mmol/l
25.5
24.9
0.32
37
212
(3021589) Normoblasts [#/volume] in Blood
436
3709
1.28
3.92
11.8
8.5
e9/l
0.0
0.0
0.72
367
3028
(3051651) Icteric interference index of Serum or Plasma
14
43
3.28
3.91
2.4
4.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
17
59
2.91
3.91
1.2
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
18
65
2.80
3.86
1.9
3.0
%
63.1
55.0
0.77
11
44
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
347
2872
1.30
3.85
2.4
2.1
u/l
194.1
237.4
0.59
332
2702
(3051611) Lipemic interference index of Serum or Plasma
19
71
2.70
3.83
2.8
3.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
48
265
1.85
3.82
1.7
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
93
616
1.55
3.78
3.5
5.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
134
2.19
3.75
2.0
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
72
450
1.64
3.73
7.0
10.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
109
2.32
3.70
2.2
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
860
7970
1.29
3.70
16.9
14.1
%
39.9
40.4
0.64
572
5505
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
34
170
2.03
3.62
2.0
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
54
315
1.75
3.61
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
68
2.67
3.57
1.6
3.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
90
602
1.54
3.52
3.4
4.1
%
0.2
0.1
0.64
33
129
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
157
1175
1.39
3.44
1.7
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
113
2.24
3.43
1.1
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
67
423
1.62
3.36
1.6
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
92
626
1.51
3.34
4.8
3.1
mmol/l
1.2
1.2
0.82
85
526
(3026493) Urate [Moles/volume] in Serum or Plasma
295
2432
1.28
3.32
3.0
2.5
umol/l
5038.7
6193.0
0.16
253
2091
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
68
434
1.60
3.27
2.5
2.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
125
911
1.42
3.20
3.0
2.5
ug/l
5.0
8.0
2.35
115
795
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
115
828
1.43
3.15
3.3
3.1
ng/l
412.0
216.5
0.50
104
761
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
121
881
1.42
3.12
1.5
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
118
2.14
3.11
1.7
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
105
2.21
3.10
2.1
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
80
539
1.52
3.06
1.6
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
117
851
1.42
3.03
3.2
3.2
mmol/l
1.9
2.1
0.19
99
676
(3025159) Blasts/100 leukocytes in Blood
84
575
1.50
2.99
3.6
4.2
%
0.0
0.8
0.52
28
117
(3037756) Immunofixation for Serum or Plasma
29
148
1.98
2.96
1.3
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
82
2.34
2.92
2.5
1.8
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
10
30
3.35
2.91
2.2
2.6
e9/l
0.1
0.2
—
10
30
(3011412) CD3 cells [#/volume] in Blood
14
52
2.71
2.89
3.1
2.4
e9/l
1.3
1.2
—
8
33
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
179
1409
1.32
2.83
1.2
1.3
iu/ml
49.4
34.2
0.33
54
441
(3017143) Hepatitis C virus Ab [Presence] in Serum
105
759
1.42
2.83
1.5
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
967
9194
1.29
2.82
17.9
12.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
86
599
1.47
2.82
2.1
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
39
224
1.77
2.80
1.6
1.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
23
3.93
2.77
2.8
2.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1029
9874
1.33
2.73
28.0
18.9
e9/l
7.1
6.8
3.16
1007
9524
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
125
2.02
2.72
2.2
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
146
1123
1.34
2.71
1.4
1.3
titre
469.1
514.8
0.15
33
247
(3007461) Platelets [#/volume] in Blood
1028
9866
1.33
2.70
28.1
18.8
e9/l
246.0
242.2
0.94
1009
9553
(3021447) Carbon dioxide [Partial pressure] in Venous blood
115
853
1.39
2.68
3.1
3.2
kpa
5.8
5.9
0.09
109
825
(3024731) MCV [Entitic volume]
1028
9869
1.33
2.67
27.9
18.8
fl
91.3
91.3
0.05
1015
9677
(3035941) MCH [Entitic mass]
1028
9870
1.32
2.66
27.9
18.7
pg
30.4
30.5
0.64
1015
9677
(3026361) Erythrocytes [#/volume] in Blood
1028
9871
1.32
2.65
28.0
18.8
e12/l
4.5
4.6
5.19
1005
9521
(3002385) Erythrocyte distribution width [Ratio]
772
7180
1.22
2.64
20.9
15.4
%
13.9
13.7
4.76
762
6989
(3000963) Hemoglobin [Mass/volume] in Blood
1028
9873
1.32
2.63
28.2
18.9
g/l
135.0
138.0
7.31
1016
9677
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
23
113
2.06
2.63
1.0
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
25
127
1.99
2.61
1.2
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
107
2.08
2.58
1.9
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
16
68
2.37
2.56
1.4
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
96
702
1.40
2.45
3.2
2.1
ml/min/173m2
82.2
66.6
0.59
43
285
(3000492) Spirometry study
107
798
1.37
2.43
1.6
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
263
2214
1.24
2.43
3.2
3.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
32
183
1.77
2.37
3.7
2.4
%
15.7
16.5
0.33
15
100
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
22
3.65
2.36
2.5
4.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
22
111
2.00
2.36
4.3
2.1
u/l
384.1
4570.8
—
9
37
(3004616) Nuclear Ab [Presence] in Serum
21
105
2.02
2.31
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
78
556
1.43
2.31
2.7
2.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
28
3.23
2.31
1.4
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
40
246
1.65
2.30
1.2
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
482
4327
1.19
2.30
5.2
3.7
ug/l
3.1
2.0
1.12
430
3879
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
371
3252
1.21
2.29
4.1
3.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
20
99
2.04
2.27
1.8
1.3
nmol/l
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
21
107
1.98
2.21
1.7
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
92
682
1.38
2.19
2.3
1.6
g/l
66.5
67.3
0.47
84
614
(4010399)
89
657
1.38
2.18
1.5
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
45
293
1.56
2.08
4.4
7.3
mmol/l
1.1
1.3
2.40
39
260
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
62
2.27
2.08
2.3
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
15
4.02
2.04
1.8
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
32
2.83
2.00
3.7
4.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
202
1688
1.24
1.99
1.3
1.2
u/ml
1.3
1.7
0.41
61
469
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
39
249
1.59
1.97
2.9
1.4
mg/l
26.3
35.5
1.13
30
199
(3034860) Kappa light chains.free [Mass/volume] in Serum
39
250
1.58
1.94
2.9
1.4
mg/l
48.7
45.8
0.12
29
201
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
25
142
1.78
1.94
1.2
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
251
1.57
1.91
2.1
2.6
u/ml
0.3
0.4
0.41
22
145
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
78
2.07
1.91
1.3
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
166
1364
1.25
1.91
1.2
1.2
u/ml
17.3
12.4
0.23
52
522
(3014051) Protein [Presence] in Urine by Test strip
31
189
1.66
1.89
2.6
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
72
2.10
1.86
1.3
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
28
2.87
1.86
1.9
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
18
93
1.95
1.85
1.1
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
31
190
1.65
1.85
4.9
3.2
umol/l
36.7
33.9
0.27
25
166
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
11
46
2.40
1.85
1.7
1.6
e6/l
416.7
1020.7
—
6
15
(3017446) Testosterone [Moles/volume] in Serum or Plasma
97
747
1.33
1.84
2.4
2.3
nmol/l
11.5
14.8
4.11
84
657
(3001019) Free T4 and TSH panel - Serum or Plasma
19
339
0.55
1.82
1.7
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
94
1.93
1.80
7.2
4.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
41
2.45
1.75
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
41
2.45
1.75
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
37
241
1.55
1.75
1.1
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
340
1.46
1.73
2.7
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
340
1.46
1.73
2.7
1.4
g/l
3.6
3.9
1.39
35
250
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
340
1.46
1.73
2.7
1.4
g/l
6.9
7.4
1.29
36
257
(4034850)
19
333
0.56
1.73
18.8
9.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
25
148
1.70
1.71
5.6
3.2
—
—
—
0
0
(44790047)
17
89
1.92
1.70
1.9
1.7
—
—
—
0
0
(44790049)
17
89
1.92
1.70
1.9
1.7
—
—
—
0
0
(44806118)
17
89
1.92
1.70
1.9
1.7
—
—
—
0
0
(44790048)
17
89
1.92
1.70
1.9
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
37
243
1.54
1.69
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
211
1.58
1.69
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
50
351
1.44
1.67
1.0
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
318
1.46
1.66
2.8
1.4
g/l
2.8
3.1
1.19
35
252
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
14
3.58
1.61
3.2
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
64
2.04
1.54
1.4
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
33
2.43
1.54
1.4
1.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
42
0.00
1.52
0.0
2.0
—
55.8
—
0
31
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
79
610
1.32
1.51
2.9
3.8
ng/l
82.4
92.0
0.53
70
534
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
36
242
1.50
1.51
1.1
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
317
1.44
1.50
2.8
1.4
g/l
9.8
10.7
0.68
37
271
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
26
162
1.62
1.50
1.0
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
29
186
1.57
1.49
2.4
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
915
8813
1.17
1.48
5.2
4.7
mmol/l
6.1
6.0
0.26
831
7999
(3000570) Elastase.pancreatic [Mass/mass] in Stool
31
204
1.53
1.44
1.7
1.4
ug/g
265.0
311.5
0.58
20
115
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
13
66
1.98
1.43
1.1
1.2
u/l
51.4
52.5
—
8
47
(4133840)
6
22
2.74
1.43
2.0
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
22
133
1.67
1.43
7.7
6.6
iu/ml
112.0
497.1
—
5
19
(40768441) Liver Pathology biopsy report
9
39
2.32
1.43
1.2
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
95
759
1.27
1.42
4.1
3.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
230
2014
1.18
1.40
3.9
3.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
29
2.42
1.39
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
14
74
1.90
1.39
1.8
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
60
2.01
1.38
1.2
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
135
1.64
1.36
1.1
1.2
u/ml
198.9
257.5
0.75
15
79
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
17
2.95
1.36
2.6
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
29
191
1.53
1.35
1.3
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
38
0.00
1.34
0.0
1.3
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
39
0.00
1.34
0.0
6.9
—
73.1
—
0
34
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
42
2.15
1.34
2.8
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
35
241
1.47
1.33
1.2
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
38
266
1.44
1.33
2.2
2.3
ug/min
110.5
120.5
0.06
20
163
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
105
1.73
1.33
1.2
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
24
2.51
1.30
1.5
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
34
2.36
1.29
1.3
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
34
2.36
1.29
1.3
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
34
2.36
1.29
1.3
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
34
2.36
1.29
1.3
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
18
2.78
1.28
1.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
18
2.78
1.28
1.4
2.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
73
574
1.29
1.26
3.4
3.4
e9/l
4.9
4.2
0.90
54
434
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
876
8445
1.15
1.25
6.6
6.1
mmol/mol
40.1
40.4
0.55
808
7814
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
92
1.75
1.25
1.5
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
242
2149
1.16
1.24
1.4
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
13
70
1.87
1.24
1.2
1.5
—
72.9
—
0
7
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
147
1.58
1.23
1.1
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
19
2.64
1.21
2.4
3.5
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
5
19
2.64
1.21
2.6
3.5
%
4.8
7.2
—
5
19
(3024354) Oxygen [Partial pressure] in Venous blood
87
704
1.25
1.20
2.5
2.6
kpa
4.6
4.5
0.19
81
676
(3021879) Hepatitis B virus core Ab [Presence] in Serum
61
472
1.31
1.19
1.3
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
38
2.11
1.18
4.1
3.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
11
57
1.94
1.17
1.0
1.2
mmol/l
10.4
11.8
—
6
21
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
39
2.06
1.15
1.0
1.1
iu/ml
520.8
272.8
—
8
39
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
55
422
1.32
1.15
1.9
2.3
%
0.6
0.7
0.79
55
410
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
35
0.00
1.15
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
30
2.34
1.12
2.6
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
58
1.90
1.12
1.1
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
73
1.79
1.11
1.8
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
66
1.83
1.09
1.5
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
27
185
1.47
1.09
1.3
1.3
iu/l
35.0
24.9
0.75
21
163
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
41
1.96
1.09
1.1
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
41
1.96
1.09
1.1
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
781
7504
1.12
1.08
23.2
16.8
g/l
332.7
333.2
0.87
775
7442
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
378
3490
1.12
1.07
4.9
3.6
%
24.0
24.1
0.04
170
1587
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
124
1057
1.19
1.06
2.0
1.9
%
1.5
1.5
0.01
109
909
(3020891) Body temperature
50
384
1.32
1.06
4.0
4.6
—
—
—
0
0
(4015189)
7
33
2.13
1.05
1.9
1.9
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
27
187
1.45
1.04
3.3
3.3
nmol/l
0.8
0.8
0.53
20
147
(3024932) HLA-DR beta [Type]
5
22
2.28
1.03
1.4
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
60
1.84
1.03
2.2
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
57
717
0.78
1.01
1.3
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
239
2157
1.14
0.98
1.7
1.6
nmol/l
19.1
20.3
0.61
214
1819
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
49
1.84
0.98
2.7
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
23
2.18
0.98
2.0
2.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
23
2.18
0.98
1.4
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
5
23
2.18
0.98
1.2
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
92
1.64
0.97
1.5
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
92
1.64
0.97
1.5
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
36
1.95
0.97
1.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
69
1.75
0.96
1.2
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
69
1.75
0.96
1.2
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
69
1.75
0.96
1.2
1.2
—
—
—
0
0
(44813793)
9
51
1.77
0.94
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
27
2.23
0.93
2.2
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
44
340
1.31
0.92
3.4
4.1
mmol/l
1.3
1.4
0.36
44
334
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
126
1.52
0.91
3.4
4.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
102
1.58
0.90
1.2
1.1
u/ml
3.6
5.7
—
9
56
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
102
1.58
0.90
1.1
1.1
u/ml
0.2
1.1
—
7
45
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
69
567
1.23
0.88
2.1
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
42
1.91
0.88
3.0
1.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
17
111
1.54
0.88
1.4
1.0
g/l
1.6
1.5
0.07
17
97
(3008898) HLA-B27 [Presence]
18
264
0.68
0.87
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
328
3040
1.11
0.86
3.9
3.2
mmol/l
7.4
8.0
1.72
275
2547
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
64
1.73
0.86
1.4
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
43
335
1.29
0.86
1.1
1.1
—
96.6
—
0
7
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
24
170
1.42
0.85
1.5
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
80
1.63
0.84
3.5
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
71
590
1.22
0.83
1.6
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
16
105
1.53
0.82
1.9
2.8
mg/l
12.2
20.2
—
6
27
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
37
285
1.31
0.81
3.2
1.3
g/l
1.1
0.4
0.60
31
247
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
38
485
0.78
0.80
1.8
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
17
114
1.50
0.79
1.1
1.1
u/ml
0.5
2.0
—
8
51
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
90
1.56
0.78
1.5
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
99
0.50
0.78
1.8
2.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
91
1.54
0.75
1.5
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
91
1.54
0.75
1.5
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
35
271
1.30
0.75
3.2
1.3
g/l
39.4
37.7
0.91
30
233
(3042733) HLA Ab [Presence] in Serum
5
24
2.09
0.74
3.0
4.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
39
1.80
0.72
1.3
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
39
1.80
0.72
4.6
3.7
—
—
—
0
0
(4281824)
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
28
211
1.33
0.72
2.5
2.0
mg/l
9.1
11.5
1.00
28
196
(3010726) Horse dander IgE Ab [Units/volume] in Serum
14
92
1.53
0.72
1.1
1.1
u/ml
0.2
6.0
—
7
23
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
51
417
1.23
0.72
5.8
3.6
mmol/l
23.6
24.3
0.67
45
371
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
40
1.75
0.71
1.4
1.4
u/l
170.7
194.4
—
7
40
(3012516) Albumin [Mass/volume] in Urine
311
2903
1.10
0.71
3.4
3.2
mg/l
273.3
210.9
0.11
210
1872
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
215
1971
1.11
0.70
1.7
1.7
pmol/l
56322269.1
36609755.7
0.13
174
1628
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
11
69
1.60
0.68
1.2
1.1
u/ml
0.4
0.4
—
5
19
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
41
330
1.25
0.67
2.3
1.8
nmol/l
32.2
39.5
2.44
41
316
(3013139) Helicobacter pylori Ag [Presence] in Stool
62
524
1.19
0.65
1.2
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
138
1.38
0.62
1.1
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29
226
1.29
0.62
1.3
1.2
u/ml
1.8
6.6
—
5
32
(3017315) Amylase [Enzymatic activity/volume] in Urine
8
51
1.57
0.60
1.4
1.3
u/l
145.3
485.6
—
8
46
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
263
1.26
0.60
1.8
1.6
iu/ml
0.1
0.2
—
6
54
(3036048) Francisella tularensis Ab [Titer] in Serum
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
8
54
1.48
0.57
1.4
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
904
8865
1.08
0.56
4.7
4.6
mmol/l
1.4
1.4
1.82
835
8146
(3011648) Oxygen content in Venous blood
11
73
1.51
0.56
2.9
1.7
%
10.1
10.5
0.12
11
73
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
37
1.62
0.55
1.2
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
38
1.58
0.54
1.2
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
9
60
1.50
0.54
1.2
1.4
mmol/l
6.6
6.8
—
9
54
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
54
460
1.18
0.54
1.2
1.2
iu/ml
46.2
129.6
2.39
16
191
(3024928) Oxygen saturation in Venous blood
25
196
1.28
0.53
2.0
2.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
323
3061
1.08
0.52
4.2
4.0
mg/mmol
9.1
8.4
0.13
218
1975
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
63
724
0.86
0.52
1.9
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
103
1144
0.89
0.51
4.8
4.7
%
31.3
32.1
0.30
76
760
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
64
1.41
0.51
1.0
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
9
64
1.41
0.51
1.0
1.7
nmol/l
16.3
19.8
—
9
55
(3009214) Lutropin [Units/volume] in Serum or Plasma
24
188
1.28
0.51
1.3
1.5
u/l
11.1
7.7
0.44
19
158
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
6
41
1.47
0.50
1.0
1.1
u/l
83.7
92.2
—
6
36
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
927
9115
1.08
0.49
5.3
5.1
mmol/l
2.7
2.7
0.09
855
8391
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
909
8932
1.08
0.49
4.8
4.6
mmol/l
4.5
4.5
0.07
848
8255
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
144
0.69
0.49
1.3
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
136
1.33
0.49
1.3
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
110
1.37
0.49
6.3
2.4
—
—
—
0
0
(4211845)
7
46
1.52
0.48
4.6
3.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
190
1.27
0.48
1.4
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
190
1.27
0.48
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
71
627
1.14
0.47
2.2
1.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
48
1.46
0.47
1.9
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
85
948
0.89
0.46
1.7
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
77
1.43
0.45
1.2
1.1
u/ml
0.5
4.2
—
6
33
(3051387) C reactive protein [Mass/volume] in Capillary blood
25
201
1.25
0.45
3.2
3.2
mg/l
28.8
27.8
0.04
17
131
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
165
1.28
0.45
1.9
1.8
—
—
—
0
0
(3004451) EKG impression Narrative
7
50
1.40
0.45
1.4
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
129
1185
1.10
0.44
10.6
6.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
873
8578
1.07
0.44
4.3
4.1
mmol/l
1.4
1.3
3.01
805
7829
(3004716) Salmonella sp identified in Stool by Organism specific culture
43
368
1.17
0.43
1.4
1.3
—
—
—
0
0
(4094501)
23
284
0.81
0.43
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
57
1.41
0.42
3.3
2.8
—
—
—
0
0
(4062490)
11
79
1.40
0.40
1.8
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
132
1.29
0.40
1.1
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
34
1.47
0.40
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
34
1.47
0.40
1.4
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
150
1.27
0.40
1.2
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
7
104
0.67
0.39
1.1
2.1
—
1616.0
—
0
5
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
35
1.43
0.39
1.2
1.0
—
7.4
—
0
6
(3003740) Influenza virus B Ag [Presence] in Specimen
15
115
1.31
0.39
1.1
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
18
142
1.27
0.38
1.3
1.3
—
15.7
—
0
6
(3035880) pH of Pleural fluid
5
36
1.39
0.38
1.2
1.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.2
—
4.7
—
0
16
(3002523) Influenza virus A Ag [Presence] in Specimen
15
116
1.30
0.37
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
253
1.19
0.37
1.3
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
171
1.23
0.36
2.2
2.0
iu/l
5.7
4.4
—
9
60
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
124
0.72
0.35
1.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
73
1.37
0.34
1.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
6
44
1.37
0.34
1.7
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
253
2416
1.06
0.34
1.5
1.7
mmol/l
1.4
1.4
0.46
206
2007
(36660697) Celiac disease serology panel - Serum
67
606
1.11
0.33
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
255
2438
1.06
0.33
2.9
2.6
ug/l
0.7
0.7
0.30
164
1571
(3000330) Specific gravity of Urine by Test strip
49
435
1.13
0.33
3.1
3.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
6
46
1.31
0.33
2.7
3.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
83
1.33
0.32
1.1
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
202
1922
1.06
0.31
4.8
3.7
kg/l
1.0
1.0
1.20
30
264
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
52
1.35
0.31
1.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
54
1.30
0.30
2.1
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
34
297
1.15
0.29
3.0
3.0
g/l
0.4
0.2
0.86
17
109
(1761482) Bacteria [#/volume] in Urine by Culture
18
217
0.83
0.29
3.1
3.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
241
1.17
0.29
2.1
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
76
1.32
0.28
1.3
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
62
1.29
0.28
1.4
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
186
1.19
0.28
1.6
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
196
1.18
0.27
2.0
2.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
65
1.23
0.27
1.4
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
187
1.18
0.26
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
178
1.18
0.26
7.6
2.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
71
0.70
0.26
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
71
0.70
0.26
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
71
0.70
0.26
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
71
0.70
0.26
1.4
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
216
1.16
0.25
1.4
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
15
123
1.22
0.25
1.8
1.7
g/l
0.6
1.0
—
10
94
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
81
0.74
0.24
1.3
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
171
1.17
0.23
1.7
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
38
1.32
0.23
3.6
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
39
1.28
0.23
1.6
1.1
—
21.3
—
0
6
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
116
1.21
0.22
1.4
1.2
u/ml
2.3
7.0
—
8
52
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
36
324
1.11
0.22
1.8
1.8
mg/l
3.8
3.1
0.13
21
234
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
17
199
0.85
0.21
1.6
1.2
e6/l
12.0
44.4
0.56
12
163
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
17
199
0.85
0.21
1.7
1.3
e6/l
3038.6
832.0
0.62
12
167
(44806071)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.3
—
13.9
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
87.5
—
0
12
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
43
1.16
0.21
1.4
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
89
1.24
0.21
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
74
787
0.94
0.19
1.5
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
51
1.18
0.19
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
51
1.18
0.19
1.0
1.0
—
—
—
0
0
(4306422)
14
118
1.19
0.19
1.4
1.2
—
—
—
0
0
(4027681)
6
52
1.15
0.19
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
81
1.24
0.18
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
59
1.19
0.18
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
163
0.86
0.17
1.1
1.4
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
7
62
1.13
0.17
1.1
1.5
mmol/l
27.1
35.4
—
7
56
(3016879) Cocaine [Presence] in Urine
24
215
1.12
0.16
7.3
2.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
70
1.14
0.16
1.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
158
1.14
0.16
1.5
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
11
92
1.20
0.16
1.0
1.2
nmol/l
1.2
1.4
0.41
11
80
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
187
1.13
0.16
1.3
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
73
1.10
0.15
1.5
1.3
—
—
—
0
0
(4268621)
9
78
1.16
0.15
2.3
2.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
82
1.10
0.15
1.6
1.8
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
22
244
0.90
0.14
1.6
1.6
e6/l
8771.5
15119.1
0.44
15
177
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
83
1.08
0.14
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
29
266
1.09
0.14
1.6
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
18
161
1.12
0.13
1.3
1.3
miu/ml
285.8
229.3
—
5
73
(3008037) Lactate [Moles/volume] in Venous blood
18
200
0.90
0.12
3.6
2.7
mmol/l
1.4
1.6
0.70
18
193
(1761868) Lipid panel - Serum or Plasma
310
3155
0.98
0.12
2.9
3.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
85
1.18
0.12
1.5
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
22
240
0.92
0.11
1.8
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
44
1.14
0.10
1.2
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
232
1.08
0.10
7.1
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
232
1.08
0.10
7.2
2.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
16
145
1.10
0.09
1.0
1.1
iu/ml
9.0
62.1
—
5
31
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
57
1.05
0.08
2.0
2.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
62
0.81
0.08
10.2
17.1
nmol/l
1465.8
1439.4
—
5
62
(3051593) INR in Capillary blood by Coagulation assay
5
62
0.81
0.08
6.4
13.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
64
1.09
0.08
1.0
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
98
1.12
0.07
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
118
1.10
0.07
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
38
364
1.05
0.06
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
48
465
1.03
0.05
1.4
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
24
228
1.05
0.05
7.4
2.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
282
0.96
0.04
1.5
2.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
18
170
1.06
0.04
1.1
1.2
u/l
109.8
19.4
0.82
11
147
(4146454)
10
109
0.92
0.04
2.5
2.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
24
230
1.04
0.03
7.5
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
17
162
1.05
0.02
1.5
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
113
1.06
0.02
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
106
1.04
0.00
2.0
2.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
18
184
0.98
0.00
3.6
2.9
mmol/l
7.8
7.5
0.31
18
177
(3044927) Protein electrophoresis panel - Urine
11
108
1.02
0.00
1.1
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
11
109
1.01
0.00
2.0
2.2
mmol/l
3.9
4.1
0.53
11
109
(3035285) Chloride [Moles/volume] in Venous blood
11
109
1.01
0.00
2.0
2.2
mmol/l
104.5
105.4
0.25
11
109
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
225
0.98
0.00
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
135
1.04
0.00
1.2
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
115
1.04
0.00
1.3
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
52
0.96
0.00
1.4
2.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
51
0.98
0.00
6.4
1.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
59
1.02
0.00
1.2
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
10
100
1.00
0.00
1.4
1.3
mmol/l
7.6
8.1
—
10
68
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
0.0
—
0
6
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.5
—
1115.8
—
0
6
(3032773) Endomysium IgG Ab [Titer] in Serum
7
70
1.00
0.00
1.1
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
5
54
0.93
0.00
1.2
1.4
u/l
4.2
7.5
—
5
46
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
73
0.96
0.00
1.4
1.5
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
0
6
0.00
0.00
0.0
1.0
—
6.1
—
0
6
(4024509)
6
67
0.89
0.00
1.5
1.5
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
5
59
0.85
0.00
1.0
1.4
—
314.0
—
0
5
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
10.8
—
0
6
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
1.7
—
1.9
—
0
7
(3025130) Human papilloma virus identified in Specimen
5
54
0.93
0.00
2.2
2.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
170
1.00
0.00
1.6
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
58
0.86
0.00
1.0
1.4
—
56.7
—
0
6
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
65
0.92
0.00
1.7
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
72
0.97
0.00
1.1
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
15.9
—
0
7
(3050129) First trimester maternal screen panel - Serum or Plasma
8
82
0.98
0.00
1.0
1.4
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
1.3
—
0
5
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
61
0.98
0.00
2.5
1.7
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
370.3
—
0
6
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
85
0.94
0.00
1.3
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_LARYNX_EXALLC – Benign neoplasm: Larynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).